API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217840
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216876
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215981
https://www.expresspharma.in/marksans-pharma-gets-uk-mhra-nod-for-diarrhoea-medication/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215579
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215001
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213484
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211438
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214541
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209837
http://www.businessinsider.com/the-fda-thinks-the-next-wave-of-drug-abuse-are-opioid-substitutes-2018-5?r=UK&IR=T
http://www.baltimoresun.com/health/bs-imodium-fda-opioid-addiction-20180321-story.html?utm_campaign=KHN%3A%20Daily%20Health%20Policy%20Report&utm_source=hs_email&utm_medium=email&utm_content=61556079&_hsenc=p2ANqtz-9RdgM4OlvW2TsvoEWd4W_YW331kcBjJ2ABD8i-faccBrh8U_Pofz-2HmNAD_I2Mh2AIWhDrcprdst_2XohYU5tMvaTew&_hsmi=61556079
http://www.wbaltv.com/article/fda-issues-opioid-abuse-warning-on-anti-diarrhea-pills/16405335
https://www.reuters.com/article/us-fda-opioid/fda-asks-drugmakers-to-limit-amount-of-opioid-drug-in-packaging-idUSKBN1FJ2C4
http://www.pharma-excipients.ch/2016/03/30/compatibility-of-different-apis-in-syrspend-sf-ph4-oral-suspensions/
http://www.pharma-excipients.ch/2016/02/02/drug-excipient-interaction-studies-of-loperamide-loaded-in-polsorbate-80-liposomes/
http://www.business-standard.com/article/companies/aurobindo-riding-higher-on-new-approvals-115122800083_1.html